SCHEMBL25689151

SCHEMBL25689151

c1ccc(-c2ccc3c(c2)[nH]c2ccc4c5ccccc5oc4c23)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK4 P11802 2/20 0.51
▸ CCND1 P24385 2/20 0.51
▸ JAK2 O60674 2/20 0.44
▸ ZAP70 P43403 1/20 0.44
▸ SYK P43405 1/20 0.44
▸ MEN1 O00255 3/20 0.42
▸ MAPT P10636 3/20 0.42
▸ KMT2A Q03164 3/20 0.42
▸ KDM4E B2RXH2 3/20 0.42
▸ GAA P10253 3/20 0.42
▸ TNKS2 Q9H2K2 1/20 0.41
▸ GABRP O00591 1/20 0.40
▸ GABRD O14764 1/20 0.40
▸ GABRA1 P14867 1/20 0.40
▸ GABRB1 P18505 1/20 0.40
▸ GABRG2 P18507 1/20 0.40
▸ GABRB3 P28472 1/20 0.40
▸ GABRA5 P31644 1/20 0.40
▸ GABRA3 P34903 1/20 0.40
▸ GABRA2 P47869 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15497546 0.97 CDK4 (0.49) CDK4CCND1JAK2ZAP70SYK
SCHEMBL24644406 0.92 CDK4 (0.49) CDK4CCND1JAK2ZAP70SYK
SCHEMBL31447816 0.92 CDK4 (0.49) CDK4CCND1JAK2ZAP70SYK
SCHEMBL25681346 0.89 GABRP (0.46) CDK4CCND1JAK2ZAP70SYK
SCHEMBL28452973 0.88 CDK4 (0.44) CDK4CCND1JAK2ZAP70SYK
SCHEMBL16482161 0.88 GABRP (0.45) CDK4CCND1JAK2ZAP70SYK
SCHEMBL22708395 0.85 CDK4 (0.48) CDK4CCND1JAK2MEN1MAPT
SCHEMBL22708536 0.84 CDK4 (0.59) CDK4CCND1MAPTKDM4ETNKS2
SCHEMBL14979113 0.84 JAK2 (0.45) CDK4CCND1JAK2ZAP70SYK
SCHEMBL24027682 0.84 JAK2 (0.42) CDK4CCND1JAK2ZAP70SYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240298538-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT KYULUX, INC. (JP) 2024-09-05 — — US disclosed
CN-117412976-A Compound, light-emitting material, and light-emitting element 九州有机光材股份有限公司 2024-01-16 — — CN disclosed
US-20230265106-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT KYULUX, INC. (JP) 2023-08-24 — — US disclosed
EP-4190791-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT Kyulux, Inc. (JP) 2023-06-07 — — EP disclosed
WO-2022249506-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT 株式会社Kyulux 2022-12-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230265106-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT CRY1, CCNE2, CRY2 CDK4 26/4885CCND1 20/4885JAK2 2128/4885
US-20240298538-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT CRY1, CRY2, TPH1 CDK4 40/4885CCND1 72/4885JAK2 2957/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback